Literature DB >> 24951956

Rap2B promotes migration and invasion of human suprarenal epithelioma.

Jie-Hui Di1, De-Bao Qu, Zheng Lu, Lian-Tao Li, Qian Cheng, Yong Xin, Long-Zhen Zhang, Yanping Zhang, Jun-Nian Zheng.   

Abstract

The aim of our study was to elucidate the role of Rap2B in the development of human suprarenal epithelioma and to investigate the effect of Rap2B on suprarenal epithelioma cells migration and invasion. We use tissue microarray and immunohistochemistry to evaluate Rap2B staining in 75 suprarenal epithelioma tissues and 75 tumor-adjacent normal renal tissues. And the expression of Rap2B protein in human suprarenal epithelioma cells and tissues was detected by western blot simultaneously. The role of Rap2B in suprarenal epithelioma cells migration and invasion was detected by using wound healing assay, cell migration assay, and matrigel invasion assay. After that, we performed western blot analysis and gelatin zymography to detect MMP-2 protein expression and enzyme activity. Our research showed that Rap2B expression was increased in tumor tissues compared with tumor-adjacent normal renal tissues. But no correlation was found between Rap2B expression and clinicopathological parameters. In addition, we found that Rap2B promoted the cell migration and invasion abilities, and Rap2B increased MMP-2 expression and enzyme activity in suprarenal epithelioma cells. Our data indicated that Rap2B expression is significantly increased in human suprarenal epithelioma and Rap2B can promote the cell migration and invasion abilities, which may provide a new target for the treatment of suprarenal epithelioma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24951956      PMCID: PMC4844085          DOI: 10.1007/s13277-014-2174-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  24 in total

1.  Phospholipase C(epsilon): a novel Ras effector.

Authors:  G G Kelley; S E Reks; J M Ondrako; A V Smrcka
Journal:  EMBO J       Date:  2001-02-15       Impact factor: 11.598

2.  Role of the CDC25 homology domain of phospholipase Cepsilon in amplification of Rap1-dependent signaling.

Authors:  T G Jin; T Satoh; Y Liao; C Song; X Gao; K Kariya ; C D Hu; T Kataoka
Journal:  J Biol Chem       Date:  2001-06-06       Impact factor: 5.157

3.  Regulation of a novel human phospholipase C, PLCepsilon, through membrane targeting by Ras.

Authors:  C Song; C D Hu; M Masago; K Kariyai; Y Yamawaki-Kataoka; M Shibatohge; D Wu; T Satoh; T Kataoka
Journal:  J Biol Chem       Date:  2000-10-05       Impact factor: 5.157

Review 4.  RNA interference.

Authors:  Gregory J Hannon
Journal:  Nature       Date:  2002-07-11       Impact factor: 49.962

5.  Differential roles of Ras and Rap1 in growth factor-dependent activation of phospholipase C epsilon.

Authors:  Chunhua Song; Takaya Satoh; Hironori Edamatsu; Dongmei Wu; Makoto Tadano; Xianlong Gao; Tohru Kataoka
Journal:  Oncogene       Date:  2002-11-21       Impact factor: 9.867

6.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

Review 7.  Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease.

Authors:  Nicolette K Janzen; Hyung L Kim; Robert A Figlin; Arie S Belldegrun
Journal:  Urol Clin North Am       Date:  2003-11       Impact factor: 2.241

8.  Hormonal regulation of phospholipase Cepsilon through distinct and overlapping pathways involving G12 and Ras family G-proteins.

Authors:  Grant G Kelley; Sarah E Reks; Alan V Smrcka
Journal:  Biochem J       Date:  2004-02-15       Impact factor: 3.857

9.  Analysis of gene function in somatic mammalian cells using small interfering RNAs.

Authors:  Sayda M Elbashir; Jens Harborth; Klaus Weber; Thomas Tuschl
Journal:  Methods       Date:  2002-02       Impact factor: 3.608

10.  Induction of matrix metalloproteinase-2 and -9 via Erk1/2-NF-κB pathway in human astroglia infected with Toxoplasma gondii.

Authors:  Cheng-You Lu; Shih-Chan Lai
Journal:  Acta Trop       Date:  2013-03-18       Impact factor: 3.112

View more
  8 in total

1.  miR-342-3p targets RAP2B to suppress proliferation and invasion of non-small cell lung cancer cells.

Authors:  Xiao Xie; Hongtao Liu; Mingsong Wang; Fangbao Ding; Haibo Xiao; Fengqing Hu; Rui Hu; Ju Mei
Journal:  Tumour Biol       Date:  2015-02-09

2.  p53 target gene Rap2B regulates the cytoskeleton and inhibits cell spreading.

Authors:  Jiehui Di; Hui Huang; Yan Wang; Debao Qu; Juanjuan Tang; Qian Cheng; Zheng Lu; Yanping Zhang; Junnian Zheng
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-12       Impact factor: 4.553

Review 3.  Rap2B GTPase: structure, functions, and regulation.

Authors:  Zhesi Zhu; Jiehui Di; Zheng Lu; Keyu Gao; Junnian Zheng
Journal:  Tumour Biol       Date:  2016-03-24

4.  Rap2B promotes cell proliferation, migration and invasion in prostate cancer.

Authors:  Jiehui Di; Huan Cao; Juangjuan Tang; Zheng Lu; Keyu Gao; Zhesi Zhu; Junnian Zheng
Journal:  Med Oncol       Date:  2016-05-06       Impact factor: 3.064

5.  Structure, functional regulation and signaling properties of Rap2B.

Authors:  Debao Qu; Hui Huang; Jiehui DI; Keyu Gao; Zheng Lu; Junnian Zheng
Journal:  Oncol Lett       Date:  2016-02-23       Impact factor: 2.967

6.  Rap2B promotes proliferation, migration, and invasion of human breast cancer through calcium-related ERK1/2 signaling pathway.

Authors:  Jiehui Di; Hui Huang; Debao Qu; Juangjuan Tang; Wenjia Cao; Zheng Lu; Qian Cheng; Jing Yang; Jin Bai; Yanping Zhang; Junnian Zheng
Journal:  Sci Rep       Date:  2015-07-23       Impact factor: 4.379

7.  Knockdown of Rap2B Inhibits the Proliferation and Invasion in Hepatocellular Carcinoma Cells.

Authors:  Li Zhang; Hong-Bin Duan; Yun-Sheng Yang
Journal:  Oncol Res       Date:  2017-01-02       Impact factor: 5.574

8.  p53 upregulates PLCε-IP3-Ca2+ pathway and inhibits autophagy through its target gene Rap2B.

Authors:  Jiehui Di; Juanjuan Tang; Heya Qian; Derek A Franklin; Chad Deisenroth; Yoko Itahana; Junnian Zheng; Yanping Zhang
Journal:  Oncotarget       Date:  2017-05-23
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.